| Literature DB >> 33683639 |
Dario Tartaglia1, Jacopo Nicolò Marin2, Alice Maria Nicoli2, Andrea De Palma2, Martina Picchi2, Serena Musetti2, Camilla Cremonini2, Stefano Salvadori3, Federico Coccolini2, Massimo Chiarugi2.
Abstract
Over the past few years, the open abdomen (OA) as a part of Damage Control Surgery (DCS) has been introduced as a surgical strategy with the intent to reduce the mortality of patients with severe abdominal sepsis. Aims of our study were to analyze the OA effects on patients with abdominal sepsis and identify predictive factors of mortality. Patients admitted to our institution with abdominal sepsis requiring OA from 2010 to 2019 were retrospectively analyzed. Primary outcomes were mortality, morbidity and definitive fascial closure (DFC). Comparison between groups was made via univariate and multivariate analyses. On 1474 patients operated for abdominal sepsis, 113 (7.6%) underwent OA. Male gender accounted for 52.2% of cases. Mean age was 68.1 ± 14.3 years. ASA score was > 2 in 87.9%. Mean BMI, APACHE II score and Mannheim Peritonitis Index were 26.4 ± 4.9, 15.3 ± 6.3, and 22.6 ± 7.3, respectively. A negative pressure wound system technique was used in 47% of the cases. Overall, mortality was 43.4%, morbidity 76.6%, and DFC rate was 97.8%. Entero-atmospheric fistula rate was 2.2%. At multivariate analysis, APACHE II score (OR 1.18; 95% CI 1.05-1.32; p = 0.005), Frailty Clinical Scale (OR 4.66; 95% CI 3.19-6.12; p < 0.0001) and ASA grade IV (OR 7.86; 95% CI 2.18-28.27; p = 0.002) were significantly associated with mortality. OA seems to be a safe and reliable treatment for critically ill patients with severe abdominal sepsis. Nonetheless, in these patients, co-morbidity and organ failure remain the major obstacles to a better prognosis.Entities:
Keywords: Abdominal sepsis; Damage control; Morbidity; Mortality; Negative pressure; Open abdomen
Mesh:
Year: 2021 PMID: 33683639 PMCID: PMC8500907 DOI: 10.1007/s13304-021-01012-8
Source DB: PubMed Journal: Updates Surg ISSN: 2038-131X
Fig. 1Amended Björck classification of open abdomen [7]
Population characteristics
| Patients | |
|---|---|
| Male gender, | 59 (52.2) |
| Age, mean ± SD | 68.1 ± 14.3 |
| BMI, mean ± SD | 26.4 ± 4.9 |
| Charlson age—comorbidity index, mean ± SD | 4.5 ± 2.3 |
| Comorbidities, | |
| Hypertension | 39 (38.2) |
| Cancer and/or chemotherapy | 30 (29.4) |
| Cardiopathy/cardiomyopathy | 21 (20.6) |
| Diabetes | 15 (14.7) |
| Pneumological disorders | 18 (17.6) |
| Obesity | 12 (11.8) |
| Immunological disorders | 11 (10.8) |
| Neurological disorders | 10 (9.8) |
| Hepatopathy | 8 (7.8) |
| Nephropathy | 7 (6.9) |
| Smoking | 4 (3.9) |
| Malnutrition | 3 (2.9) |
| Immunosuppression/steroid use | 3 (2.9) |
| Aneurism | 3 (2.9) |
| Presence of ostomy | 4 (3.9) |
| None | 4 (3.9) |
| Other | 46 (45.1) |
| ASA, | |
| I | 1 (1.0) |
| II | 11 (11.1) |
| III | 37 (37.4) |
| IV | 50 (50.5) |
| Mannheim peritonitis index, mean ± SD | 22.6 ± 7.3 |
| APACHE II score, mean ± SD | 15.3 ± 6.3 |
| Time to surgery (hours), mean ± SD | 9.2 ± 6.7 |
| Frailty clinical scale, median (IQR) | 7 (1–9) |
BMI body mass index, ASA American society of Anesthesiology score, APACHE II acute physiology and chronic health evaluation II score, SD standard deviation, IQR interquartile range
aBased on 99 pts with available ASA score data
Perioperative variables during OA treatment
| TAC technique adopted at first look, | |
|---|---|
| NPWT with commercial kits | 53 (46.9) |
| Vacuum-pack technique | 38 (33.6) |
| Skin-closure | 18 (15.9) |
| Mesh-mediated NPWT | 4 (3.5) |
| OA* duration, mean ± SD | 2.8 ± 1.7 |
| Number of looks, mean ± SD | 1.2 ± 0.8 |
| ICU length of stay, mean ± SD | 13.7 ± 12.8 |
| Type of nutrition, | |
| Parenteral | 96 (95.0) |
| Enteral | 2 (2.0) |
| Enteral + parenteral | 3 (3.0) |
TAC temporary abdominal closure, NPWT negative pressure wound technique, OA open abdomen, ICU intensive care unit, SD standard deviation
Fig. 2Distribution of amended Björck classification grades at 2nd look
Patients’ outcomes
| Perioperative mortality, | |
|---|---|
| Overall | 49/113 (43.4) |
| During OA | 20/49 (40.8) |
| After definitive closure | 29/49 (59.2) |
| Causes of mortality, | |
| Cardiopulmonary complications | |
| Overall | 27/49 (55) |
| During OA | 8/20 (40) |
| After definitive closure | 19/29 (65) |
| Multiorgan failure due to sepsis | |
| Overall | 20/49 (41) |
| During OA | 11/20 (55) |
| After definitive closure | 9/29 (31) |
| Irreversible brain damage | |
| Overall | 2/49 (4) |
| During OA | 1/20 (5) |
| After definitive closure | 1/29 (4) |
| Definitive fascial closure, | 91/93 (97.8) |
| Definitive cutaneous closure, | 88/93 (94.6) |
| Prosthetic mesh, | 10/93 (10.8) |
| Overall postoperative complications, | 49/64 (76.6) |
| Reinterventions, | 20/93 (21.5) |
| Entero-atmospheric fistula, | 2/93 (2.2) |
OA open abdomen
Univariate analysis between survivors and non-survivors groups
| Survivors | Non-survivors | ||
|---|---|---|---|
| Male gender, | 33 (51.6) | 26 (53.1) | 0.87 |
| Age, mean ± SD | 65.8 ± 14.0 | 71.2 ± 14.3 | |
| BMI, mean ± SD | 26.6 ± 5.0 | 26.1 ± 4.6 | 0.59 |
| Charlson age-comorbidity, mean ± SD | 4.2 ± 2.6 | 5.0 ± 1.8 | 0.07 |
| Comorbidities, | |||
| Hypertension | 23 (37.1) | 16 (40.0) | 0.77 |
| Cancer and/or chemotherapy | 20 (32.3) | 10 (25.0) | 0.43 |
| Cardiopathy/cardiomyopathy | 10 (16.1) | 11 (27.5) | 0.17 |
| Diabetes | 9 (14.5) | 6 (15.0) | 0.95 |
| Pneumological disorders | 9 (14.5) | 9 (22.5) | 0.30 |
| Obesity | 8 (12.9) | 4 (10.0) | 0.76 |
| Immunological disorders | 7 (11.3) | 4 (10.0) | 1.00 |
| Neurological disorders | 3 (4.8) | 7 (17.5) | |
| Hepatopathy | 3 (4.8) | 5 (12.5) | 0.16 |
| Nephropathy | 3 (4.8) | 4 (10.0) | 0.43 |
| Smoking | 4 (6.5) | 0 (0) | 0.15 |
| Malnutrition | 1 (1.6) | 2 (5.0) | 0.56 |
| Immunosuppression/steroids | 0 (0) | 3 (7.5) | 0.06 |
| Aneurism | 0 (0) | 3 (7.5) | 0.06 |
| Presence of ostomy | 4 (6.5) | 0 (0) | 0.15 |
| Other | 29 (46.8) | 17 (42.5) | 0.67 |
| None | 4 (6.5) | 0 (0) | 0.15 |
| ASA IVa, | 23 (35.9) | 27 (55.1) | |
| Mannheim Peritonitis Index ≥ 30b, | 6 (9.4) | 9 (18.4) | 0.16 |
| APACHE II score, mean ± SD | 13.2 ± 5.3 | 18.4 ± 6.6 | |
| Time to surgery (hours), mean ± SD | 8.87 ± 6.48 | 9.63 ± 7.16 | 0.71 |
| Frailty clinical scale, median (IQR) | 3 (1–8) | 4 (2–9) | |
| TAC technique, | 0.29 | ||
| NPWT | 27 (42.2) | 26 (53.1) | |
| Vacuum-pack technique | 24 (37.5) | 14 (28.6) | |
| Skin-closure | 12 (18.8) | 6 (12.2) | |
| Mesh-mediated NPWT | 1 (1.6) | 3 (6.1) | |
| 1A Björck’s grade at 2nd lookc, | 31 (48.4) | 18 (36.7) | 0.21 |
| Number of looks, mean ± SD | 1.3 ± 0.6 | 1.1 ± 1.1 | 0.15 |
| OA duration, mean ± SD | 2.9 ± 1.8 | 2.6 ± 1.6 | 0.54 |
| ICU length of stay, mean ± SD | 14.5 ± 10.6 | 12.4 ± 15.5 | 0.44 |
In bold are reported p values, rounded to second decimal, inferior to significance level
BMI body mass index, ASA American society of anesthesiology score, APACHE II acute physiology and chronic health evaluation II score, TAC temporary abdominal closure, NPWT negative pressure wound technique, OA open abdomen, ICU intensive care unit, SD standard deviation, IQR interquartile range
aThe analysis was carried out by two levels “IV” and “III or less”, considering the distribution of the four levels within the sample
bThe analysis was carried out by two levels “30 or over” and “29 or less”, considering the distribution within the sample
cThe analysis was carried out by two levels “1A” and “1B or over”, considering the distribution within the sample
Multivariate analysis
| OR | 95% CI | ||
|---|---|---|---|
| Step 1 | |||
| Age | 0.99 | 0.94 – 1.04 | 0.73 |
| Male | 1.29 | 0.32 – 5.13 | 0.72 |
| Neurological disorders | 2.26 | 0.27 – 19.23 | 0.46 |
| MPI | 2.63 | 0.51 – 13.53 | 0.25 |
| Frialty clinical scale | 0.60 | 0.12 – 1.08 | |
| Apache II | 1.20 | 1.05 – 1.37 | |
| ASA IV | 6.74 | 1.78 – 25.47 | |
| Step 5 | |||
| Frialty clinical scale | 4.66 | 3.19 – 6.12 | < |
| Apache II | 1.18 | 1.05 – 1.32 | |
| ASA | |||
| IV | 7.86 | 2.18 – 28.27 | |
| III or less | 1.00 | ||
Analysis is carried out with a binary logistic regression model with Stepwise backward selection mode. In bold are reported p values inferior to significance level
MPI Mannheim peritonitis index, ASA American society of anesthesiology score, APACHE II acute physiology and chronic health evaluation II s